These findings encourage researchers to use molecular component identification to study the effects of obesity on the von Willebrand factor (VWF)/ADAMTS13 axis, COVID-19 pathogenesis, and outcomes. This evidence concerns the gene VWF and obesity due to melanocortin 4 receptor deficiency.